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Significant Pharmacological Activities
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Abstract
Acanthus ilicifolius Linn. (Acanthaceae) is relatively lesser-known, yet
important medicinal plant of Herbal Materia Medica. The plant is used in traditional
systems of medicine, including Traditional Indian Medicine (TIM) or Ayurveda and
Traditional Chinese Medicine (TCM). The plant is reported to contain phytochemicals
including alkaloid and wide range of glucosides (lignan and phenylethanoid). In
traditional medicine, the plant is used in the treatment of diseases ranging from snake
bite to skin diseases. Laboratory investigations on extracts of the plant have
demonstrated significant pharmacological activities like antioxidant, anticarcinogenic,
anti-osteporotic and hepatoprotective. The review analyses traditional medicinal usage,
and phyto-pharmacological investigations done on the medicinal plant.
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Introduction

Acanthus ilicifolius (sea holly) occurs in tropical Asia and Africa, through Malaya to Polynesia. It
is a viny shrub or tall herb, upto 1.5 m high, scarcely woody, bushy, with very dense growth. Shallow
tap roots, but occasionally stilt roots are conspicuous. Leaf simple, opposite, decussate, cauline,
exstipulate, petiole short, flattened, glabrous, pulvinous to sheathing base. Flower bisexual, typically
zygomorphic, complete, erect, sessile, hypogynous. Fruit 1 cm green and 2.5 - 2.0 cm long, kidney
shaped 4 seed drupe, Seed 0.5 - 1.0 cm long (Xie et al 2005).
Phytochemistry
Two new cyclolignan glycosides, (+)-lyoniresinol 3a-O-β-D-galactopyranosyl-(1 → 6)-β-Dglucopyranoside and (+)-lyoniresinol 2a-O-β-D-galactopyranosyl-3a-O-β-D-glucopyranoside have
been reported from aerial parts of A. ilicifolius (Zhang et al 2004). A phenylethanoid glycoside
(ilicifolioside A) and an aliphatic alcohol glycoside (ilicifolioside B) have been isolated from the aerial
parts (Kanchanapoom et al 2002). Two lignan glucosides, (+)-lyoniresinol 3a-[2-(3, 5-dimethoxy-4hydroxy)-benzoyl]-O-beta-glucopyranoside, and dihydroxymethyl-bis (3, 5-dimethoxy-4hydroxyphenyl) tetrahydrofuran-9(or 9')-O-beta-glucopyranoside have been isolated from the aerial
parts (Kanchanapoom et al 2001). 11-epoxymegastigmane glucoside and megastigmane glucosides
(roseoside) have been reported from a A. ilicifolius growing in China (Wu et al 2003). 2benzoxazolinone and blepharin have been reported from plant growing in Vietnam (Nagao et al 2005).
A new coumaric acid derivative acancifoliuside, acteoside, isoacteoside, acanthaminoside, (+)lyoniresinol 3a-O-beta-glucopyranoside, (-)-lyoniresinol, and alpha-amyrin , have been isolated from
the methanolic extract of the leaves of A. ilicifolius (Huo et al 2008).
Traditional Medicinal Uses (Mastaller, 1997)
Malaysia: The leaves of A. ilicifolius are used to treat rheumatism, neuralgia and poison arrow wounds.
It is widely believed among mangrove dwellers that chewing the leaves will protect against snake bite.
Malay: The pounded seeds of A. ilicifolius and A. ebracteatus are used to treat boils, and the juice of
leaves to prevent alopecia. Both species are also used to treat urolithiasis.
India: In Ayurveda, the plant is known as Sahachara. According to Nadkarni the drug is astringent and
makes a good nervine tonic, expectorant, and stimulant. He says that the root is expectorant, and is
used in coughs and asthma. The root, boiled in milk, is largely used in leucorrhoea and general
debility. Loureiro says that the Siamese and Indo-Chinese consider the roots to be cordial and
attenuant, and useful in paralysis and asthma. The tender shoots and leaves are used in India for bite. In
Goa, the leaves, which abound in mucilage, are used as an emollient fomentation in rheumatism and

neuralgia.
Thailand: Water extracted from the bark is used to treat colds and dermatitis. Ground fresh bark is used
as an antiseptic. Tea brewed from the leaves relieves pain and purifies the blood.
Pharmacology
Anti-inflammatory
The methanolic fraction of A. ilicifolius leaf extract produced significant inhibition of rat paw
oedema, when administered both prior to and after carrageenan administration, in a manner similar to
BW755C a synthetic cyclooxygenase and lipoxygenase inhibitor. The extract decreased protein
exudation and leukocyte migration in the peritoneal fluid, thereby indicating its effectiveness towards
inhibiting peritoneal inflammation. It also produced significant inhibition of cyclooxygenase (1 and 2)
and lipoxygenase activity. Preincubation of the extract inhibited the production of proinflammatory
cytokines in lipopolysaccharide stimulated peripheral blood mononuclear cells.
The methanolic fraction of the extract was also found to possess significant free radical scavenging
activity. The extract on intraperitoneal administration augmented the endogenous antioxidant status, as
evident from the significant increase of ferric reducing ability of plasma and total peroxyl radical
trapping activity of plasma (Kumar et al 2008).
Anti-osteoporotic activity
The effects of the compounds isolated from A. ilicifolius on the function of osteoblastic MC3T3-E1
cells were tested. Acteoside, isoacteoside, and (+)-lyoniresinol 3a-O-beta-glucopyranoside (30
microM) increased the growth and differentiation of osteoblasts significantly (P<0.05), indicating that
A. ilicifolius leaves may help prevent osteoporosis (Van Kiem et al 2008).
Hepatoprotective
The alcoholic extract of A. ilicifolius leaves inhibited the formation of oxygen derived free radicals
in vitro with IC (50) of 550 microg/ml, 2750 microg/ml, 670 microg/ml and 600 microg/ml (Fe (2+)/
ascorbate system), 980 microg/ml (Fe (3+)/ADP/ascorbate system) for superoxide radical production,
hydroxyl radical generation, nitric oxide radical formation and lipid peroxide formation, respectively.
The oral administration of the extract (250 and 500 mg/kg) significantly reduced CCl4 induced
hepatotoxicity in rats, as judged from the serum and tissue activity of marker enzymes; glutamate
oxaloacetate transaminase, glutamate pyruvate transaminase and alkaline phosphatase. The results
were comparable with those obtained with curcumin {100 mg/kg, p.o.} (Babu et al 2001).
Chemo preventive
A. To investigate the chemo preventive efficacy of A. ilicifolius in a transplantable Ehrlich ascites
carcinoma (EAC)-bearing murine model, male Swiss albino mice were divided into four groups: Group

A was the untreated normal control; Group B was the Ehrlich ascites carcinoma control mice group
that received serial, intraperitoneal (ip) inoculations of rapidly proliferating 2 x 10(5) viable Ehrlich
ascites carcinoma cells in 0.2 mL of sterile phosphate buffered saline; Group C was the plant extracttreated group that received the aqueous leaf extract of A. ilicifolius at a dose of 2.5 mg/kg body weight
by single ip injections, once daily for 10, 20 and 30 consecutive days following tumour inoculation
(aqueous leaf extract of A. ilicifolius); and Group D was the Ehrlich ascites carcinoma + aqueous leaf
extract of A. ilicifolius treatment group (Chakraborty et al 2007).
The chemopreventive potential of the aqueous leaf extract of A. ilicifolius was evaluated in a
murine model by studying various biological parameters and genotoxic markers, such as tumour cell
count, mean survival of the animals, haematological indices, hepatocellular histology, immunohistochemical expression of liver metallothionein protein, sister-chromatid exchanges, and DNA
alterations. Treatment of the Ehrlich ascites carcinoma -bearing mice with the aqueous leaf extract of
A. ilicifolius significantly (P < 0.001) reduced viable tumour cell count by 68.34% (228.7 x 10(6) +/0.53) when compared to Ehrlich ascites carcinoma control mice (72.4 x 10(6) +/- 0.49), and restored
body and organ weights almost to the normal values. Aqueous leaf extract of A. ilicifolius
administration also increased (P < 0.001) mean survival of the hosts from 35 +/- 3.46 d in Ehrlich
ascites carcinoma control mice to 83 +/- 2.69 d in Ehrlich ascites carcinoma + aqueous leaf extract of
A. ilicifolius treated mice.
B. Alcoholic extract of A. ilicifolius (250, 500 mg/kg b wt) was found to be effective against
tumour progression and carcinogen induced skin papilloma formation in mice. The extract was found
to be cytotoxic towards lung fibroblast (L-929) cells in 72 h MTT assay and the concentration required
for 50% cell death was 18 μg/ml. Oral administration of the extract (500 mg/kg b wt) reduced the
tumour volume and administration of the same concentration increased the life span by 75% in ascites
tumour harbouring animals. The extract also significantly delayed the onset of dimethylbenzanthrazene/
Croton oil induced skin papilloma in mice in a dose dependent manner (Babu, Shylesh and Padikkala,
2002)
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